EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Utility of BioFire FilmArray Pneumonia Panel Plus in a High‐Risk Cohort: Children Post Allogeneic Stem Cell Transplantation

Hannah Walker iD, Theresa Cole, Liam Gubbels, Helen Pham, Melanie Neeland, Diane Hanna, Vanessa Clifford, Shivanthan Shanthikumar iD, Gabrielle M Haeusler

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31940 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Hannah Walker und 8 weiteren Autor:innen. Beteiligte Einrichtung: Children's Cancer Centre, Royal Children's Hospital, Parkville, Australia. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Multiplex Polymerase Chain Reaction, Bronchoalveolar Lavage Fluid, Pneumonia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: My Room Children's Cancer Charity, The Bella Tripp Foundation, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pulmonary complications due to infection contribute significantly to post‐haematopoietic stem cell transplant (HCT) morbidity and mortality. Standard microbiological investigations, when performed on bronchoalveolar lavage (BAL) fluid, can take days to weeks to confirm a diagnosis. We aimed to determine the diagnostic performance of the BioFire FilmArray pneumonia panel plus (FA‐PP), a multiplex polymerase chain reaction (PCR) panel that detects 18 bacterial and nine viral targets, when applied to BAL obtained by flexible bronchoscopy, in children undergoing HCT.

Methods

We performed a single‐centre prospective observational study in children undergoing allogeneic HCT, who underwent BAL pre‐ and post‐HCT. To determine the diagnostic performance of the FA‐PP, we measured the positive and negative concordance, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV), compared with standard microbiological investigations, which was considered the gold standard. The clinical impact of the FA‐PP was also qualitatively measured.

Results

This study enrolled 16 children who had 31 BAL samples collected, both pre‐ and post‐HCT. In total, there were seven patients who underwent eight BALs while symptomatic, and 50% (4/8) of these results were concordant between FA‐PP and standard microbiological investigations. In the 13 patients who had 23 BALs collected while asymptomatic, 78% (18/23) of these results were concordant. In the cohort as a whole, sensitivity, specificity, PPV and NPV were 100%, 78%, 54% and 100%, respectively. In 50% (4/8) of patients who underwent a BAL while symptomatic, the FA‐PP resulted in a hypothetical or actual clinical change, compared to 22% (5/23) of patients who underwent an asymptomatic BAL.

Conclusion

In conclusion, we report the first prospective evaluation of the diagnostic performance of the FA‐PP in BAL, in a high‐risk paediatric HCT cohort. We demonstrate that the FA‐PP is a potentially useful adjunct to traditional standard microbiological investigations that can provide clinically impactful diagnostic information.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationMultiplex Polymerase Chain ReactionBronchoalveolar Lavage FluidPneumoniaHumansMaleFemaleChild, PreschoolChildProspective StudiesInfantAdolescentTransplantation, HomologousFollow-Up StudiesPrognosis

Stichwörter der Autor:innen

haematopoietic stem cell transplant | paediatric | pulmonary complications

Autor:innen und Institutionen

  • Children's Cancer Centre, Royal Children's Hospital, Parkville, Australia.
  • Department of Paediatrics, University of Melbourne, Parkville, Australia.
  • Murdoch Children's Research Institute, Parkville, Australia.
  • Allergy and Immunology, Royal Children's Hospital, Parkville, Australia.
  • Laboratory Services, Royal Children's Hospital, Parkville, Australia.
  • Department of Infection Diseases, Royal Children's Hospital, Parkville, Australia.

ORCID-Profile: Hannah Walker, Shivanthan Shanthikumar

Förderung

  • My Room Children's Cancer Charity
  • The Bella Tripp Foundation
  • National Health and Medical Research Council
  • Kids' Cancer Project

Zitieren

APA

Walker, H., Cole, T., Gubbels, L., Pham, H., Neeland, M., Hanna, D., Clifford, V., Shanthikumar, S., & Haeusler, G. M. (2025). Utility of BioFire FilmArray Pneumonia Panel Plus in a High‐Risk Cohort: Children Post Allogeneic Stem Cell Transplantation. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31940

Vancouver

Walker H, Cole T, Gubbels L, Pham H, Neeland M, Hanna D, et al. Utility of BioFire FilmArray Pneumonia Panel Plus in a High‐Risk Cohort: Children Post Allogeneic Stem Cell Transplantation. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31940

BibTeX
@article{Walker2025,
  author = {Walker, Hannah and Cole, Theresa and Gubbels, Liam and Pham, Helen and Neeland, Melanie and Hanna, Diane and Clifford, Vanessa and Shanthikumar, Shivanthan and Haeusler, Gabrielle M},
  title = {Utility of BioFire FilmArray Pneumonia Panel Plus in a High‐Risk Cohort: Children Post Allogeneic Stem Cell Transplantation},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31940}
}
Kostenlos starten →